Wed, September 25, 2024

Jason McCarthy Maintained (CAPR) at Strong Buy with Increased Target to $25 on, Sep 25th, 2024

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-25-on-sep-25th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Jason McCarthy of Maxim Group, Maintained "Capricor Therapeutics, Inc." (CAPR) at Strong Buy with Increased Target from $12 to $25 on, Sep 25th, 2024.

Jason has made no other calls on CAPR in the last 4 months.



There are 2 other peers that have a rating on CAPR. Out of the 2 peers that are also analyzing CAPR, 0 agree with Jason's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Jason


  • Joseph Pantginis of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $40 on, Tuesday, September 24th, 2024
  • Kristen Kluska of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $8 on, Friday, September 20th, 2024